TSE:4536Pharmaceuticals
How Investors Are Reacting To Santen Pharmaceutical (TSE:4536) Raising Dividends And Issuing 2027 Earnings Guidance
On 12 May 2026, Santen Pharmaceutical Co., Ltd. raised its expected interim and year-end dividends for the fiscal year ending 31 March 2027 to ¥21.00 per share, while also affirming a ¥19.00 year-end dividend for the fiscal year ended 31 March 2026.
The company also issued new consolidated guidance for the year to March 2027, projecting revenue of ¥311,000 million, operating profit of ¥49,500 million, net profit of ¥39,500 million and basic earnings per share of ¥124.42, signaling confidence...